Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Horizon Therapeutics Public Limited Company (HZNP : NSDQ)
 
 • Company Description   
Horizon Therapeutics PLC is a biopharmaceutical company. It is focused on identifying, developing, acquiring and commercializing differentiated and accessible medicines which address unmet medical needs. The Company markets medicines through its orphan, rheumatology and primary care business units. Horizon Therapeutics PLC, formerly known as Horizon Pharma Public Limited Company, is headquartered in Dublin, Ireland.

Number of Employees: 1,890

 
 • Price / Volume Information   
Yesterday's Closing Price: $90.35 Daily Weekly Monthly
20 Day Moving Average: 2,245,871 shares
Shares Outstanding: 229.88 (millions)
Market Capitalization: $20,770.02 (millions)
Beta: 1.11
52 Week High: $120.48
52 Week Low: $82.51
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -18.23% -7.91%
12 Week -2.66% 7.00%
Year To Date -16.16% 1.30%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
70 St. Stephen's Green
-
Dublin 2,L2 D02 E2X4
IRL
ph: 011-353-1772-2100
fax: 224-383-3001
investor-relations@horizontherapeutics.com http://www.horizontherapeutics.com
 
 • General Corporate Information   
Officers
Timothy P. Walbert - President; Chief Executive Officer and Chairman of
Paul W. Hoelscher - Executive Vice President and Chief Financial Offic
Miles W. McHugh - Senior Vice President and Chief Accounting Officer
Michael Grey - Director
William F. Daniel - Director

Peer Information
Horizon Therapeutics Public Limited Company (CORR.)
Horizon Therapeutics Public Limited Company (RSPI)
Horizon Therapeutics Public Limited Company (CGXP)
Horizon Therapeutics Public Limited Company (BGEN)
Horizon Therapeutics Public Limited Company (GTBP)
Horizon Therapeutics Public Limited Company (RGRX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: G46188101
SIC: 2834
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/03/22
Share - Related Items
Shares Outstanding: 229.88
Most Recent Split Date: (:1)
Beta: 1.11
Market Capitalization: $20,770.02 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $1.36 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $5.59 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 5.00 Change In Payout Ratio: 0.00
Estmated Long-Term EPS Growth Rate: 12.73% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/03/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 16.17
Trailing 12 Months: 14.76
PEG Ratio: 1.27
Price Ratios
Price/Book: 4.31
Price/Cash Flow: 14.03
Price / Sales: 5.51
EPS Growth
vs. Year Ago Period: 4,366.67%
vs. Previous Quarter: -4.96%
Sales Growth
vs. Year Ago Period: 158.54%
vs. Previous Quarter: -12.74%
ROE
03/31/22 - 32.08
12/31/21 - 26.66
09/30/21 - 26.85
ROA
03/31/22 - 16.88
12/31/21 - 13.64
09/30/21 - 14.33
Current Ratio
03/31/22 - 3.57
12/31/21 - 3.16
09/30/21 - 2.83
Quick Ratio
03/31/22 - 3.30
12/31/21 - 2.90
09/30/21 - 2.55
Operating Margin
03/31/22 - 38.33
12/31/21 - 35.23
09/30/21 - 37.23
Net Margin
03/31/22 - 22.87
12/31/21 - 16.57
09/30/21 - 18.66
Pre-Tax Margin
03/31/22 - 21.40
12/31/21 - 14.35
09/30/21 - 16.28
Book Value
03/31/22 - 20.96
12/31/21 - 20.60
09/30/21 - 19.62
Inventory Turnover
03/31/22 - 3.83
12/31/21 - 3.31
09/30/21 - 3.53
Debt-to-Equity
03/31/22 - 0.53
12/31/21 - 0.55
09/30/21 - 0.57
Debt-to-Capital
03/31/22 - 34.63
12/31/21 - 35.35
09/30/21 - 36.50
 

Powered by Zacks Investment Research ©